Onglyza Wrongful Death and Death Rate Increase
Wrongful Death from Heart Failure
The growing incidence of adults developing Type 2 diabetes in the United States has led to the development of new diabetes medications. The problem with this is that many of the newer diabetes drugs approved for use by the U.S. Food and Drug Administration (FDA) may not have been thoroughly tested for safety. Recent studies have suggested a link between Onglyza, one of these newer diabetes treatments, and increased death risk.
If a loved one has suffered severe side effects or died after being prescribed Onglyza, you and your family may be able to pursue compensation for wrongful death damages. Pharmaceutical companies are large, wealthy entities with deep pockets and armies of lawyers working for them. To succeed in a claim against a pharmaceutical giant, you will need a skilled and aggressive legal team representing your case.
Farah & Farah is passionate in our mission to fight for the rights of families verses huge corporations and their insurers. We are currently investigating Onglyza wrongful death cases nationwide. Call Farah & Farah today at (800) 533-3555 for a free consultation with an Onglyza lawyer.
What is Onglyza?
Onglyza is the brand name for the medication saxagliptin. It is in a class of Type 2 diabetes drugs known as incretin mimetics. Incretin mimetics work by stimulating the release of insulin to manage the body’s blood sugar. The Swedish-British pharmaceutical company AstraZeneca devloped Onglyza. The drug was approved for use by the U.S. Food and Drug Administration (FDA) in 2009.
Studies Show Link Between Onglyza and Increased Disease Risk
Recent studies, including one published in the New England Journal of Medicine, show connections between Onglyza use and an increased risk for heart failure, pancreatic cancer, and other serious issues. The New England Journal of Medicine found a 27 percent increase in risk of heart failure among patients taking Onglyza. No recall has been issued for Onglyza, but the FDA issued a 2015 statement that associated taking Onglyza with “significant or near-significant” increased death risks.
Nationwide Onglyza Lawsuits
Many wrongful death claims have been filed against AstraZeneca since the link between Onglyza use and heart failure was found. AstraZeneca is facing lawsuits nationwide for failing to warn of potential health risks, fraudulent marketing of the drug, and failure to conduct adequate pre-market testing.
Damages in a Wrongful Death Suit
If you have lost a loved one and believe Onglyza to be the cause of their death, you and your family may be able to pursue wrongful death damages such as:
- Medical bills
- Pain and suffering of the deceased before they died
- Funeral and burial expenses
- Loss of future income
- Loss of future benefits (such as medical and retirement benefits)
- Mental anguish and emotional duress
- Loss of love, affection, companionship, guidance, marital consortium, etc.
- Loss of household services the deceased performed (such as child care, vehicle and property maintenance, chores, etc.)
Contact an Onglyza Death Lawyer at Farah & Farah
If you have lost a family member as the result of taking Onglyza, you need to consult a pharmaceutical litigation wrongful death attorney. The skilled Onglyza death attorneys at Farah & Farah has represented families in wrongful death claims for decades. We are currently investigating wrongful death claims related to Onglyza use nationwide.
Call Farah & Farah today at (800) 533-3555 to schedule a free consultation.
Need help now? Speak with a
Patient Advocate now: